ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,400Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 973

$1.13M Total Retail Price of All Prescriptions

Rank: 7 out of 973

699 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 699 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

28% of this provider’s 699 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 17,129 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
HYDROCODONE-ACETAMINOPHEN 934 680 S3 1 4
LISINOPRIL 784 645 2 3
FUROSEMIDE 703 595 3 6
OMEPRAZOLE 670 518 4 5
LEVOTHYROXINE SODIUM 547 430 5 2
SIMVASTATIN 466 377 6 1
AMLODIPINE BESYLATE 462 349 7 7
TRAMADOL HCL 374 268 8 18
GABAPENTIN 358 258 9 12
METOPROLOL TARTRATE 355 214 10 13
POTASSIUM CHLORIDE 352 301 11 9
METFORMIN HCL 344 226 12 8
CITALOPRAM HBR 325 265 13 14
CARVEDILOL 324 279 14 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 303 192 15 25
WARFARIN SODIUM 266 232 16 10
ZOLPIDEM TARTRATE 242 205 17 20
MIRTAZAPINE 227 198 18 43
NEXIUM 224 174 19 30
RANITIDINE HCL 216 151 20 45
CLONIDINE HCL 212 196 21 67
PANTOPRAZOLE SODIUM 207 164 22 37
PAROXETINE HCL 206 177 23 66
CLOPIDOGREL 186 162 24 44
ATENOLOL 186 158 24 16
CYCLOBENZAPRINE HCL 183 118 R 26 42
NYSTATIN 183 149 26 149
DIGOXIN 182 164 28 32
KLOR-CON 10 179 163 29 128
AMOXICILLIN 176 134 30 101
DOXYCYCLINE HYCLATE 174 136 31 96
DOXAZOSIN MESYLATE 173 145 32 87
QUETIAPINE FUMARATE 169 122 33 70
ALLOPURINOL 152 133 34 29
HYDROCHLOROTHIAZIDE 148 103 35 11
TRAZODONE HCL 147 84 36 48
PLAVIX 139 120 37 78
TAMSULOSIN HCL 138 119 38 28
MELOXICAM 135 114 39 23
PRAVASTATIN SODIUM 134 106 40 22
DONEPEZIL HCL 133 133 41 26
LANTUS 132 86 42 39
SERTRALINE HCL 131 98 43 21
METOPROLOL SUCCINATE 126 86 44 17
CRESTOR 125 99 45 34
SPIRIVA 120 66 46 73
LOSARTAN POTASSIUM 119 78 47 19
PROAIR HFA 117 56 48 54
NAPROXEN 116 68 49 94
PREDNISONE 116 85 49 33
ROPINIROLE HCL 115 99 51 72
CARBIDOPA-LEVODOPA 114 114 52 71
METOLAZONE 109 83 53 170
NAMENDA 108 98 54 31
FAMOTIDINE 107 95 55 61
PHENYTOIN SODIUM EXTENDED 106 78 56 141
ATORVASTATIN CALCIUM 105 89 57 15
AZITHROMYCIN 104 86 58 47
FENTANYL 103 80 S2 59 53
NOVOLOG 103 92 59 82
GLYBURIDE 102 84 R 61 59
DIVALPROEX SODIUM 101 56 62 86
ISOSORBIDE MONONITRATE ER 100 93 63 85
ALENDRONATE SODIUM 98 83 64 24
GLIMEPIRIDE 97 74 65 41
ADVAIR DISKUS 96 61 66 60
RISPERIDONE 95 64 67 65
CYMBALTA 95 59 67 40
MUPIROCIN 90 78 69 151
SULFAMETHOXAZOLE-TRIMETHOPRIM 88 73 70 76
OLANZAPINE 88 56 70 122
HYDROXYZINE HCL 87 45 R 72 190
SINGULAIR 86 45 73 106
COMBIVENT 83 69 74 186
EVISTA 81 37 75 121
BENZTROPINE MESYLATE 81 27 R 75 124
FLUOXETINE HCL 78 45 77 56
ESCITALOPRAM OXALATE 78 60 77 68
TERAZOSIN HCL 77 37 79 112
IBUPROFEN 77 60 79 102
SPIRONOLACTONE 77 54 79 49
TRIAMCINOLONE ACETONIDE 77 66 79 120
KLOR-CON M10 75 46 83 130
MEGESTROL ACETATE 74 64 R 84 188
HYDROCORTISONE 74 54 84 221
KLOR-CON M20 73 44 86 64
DILTIAZEM 24HR CD 73 52 86 104
CIPROFLOXACIN HCL 73 67 86 57
AMLODIPINE BESYLATE-BENAZEPRIL 72 60 89 80
LEVEMIR 72 63 89 207
OXYBUTYNIN CHLORIDE 71 58 91 92
AMOX TR-POTASSIUM CLAVULANATE 70 48 92 160
TRIAMTERENE-HCTZ 70 54 92 51
OXYCODONE-ACETAMINOPHEN 70 60 S2 92 89
GLIPIZIDE 69 58 95 69
PROCHLORPERAZINE MALEATE 67 41 96 293
ESTRADIOL 67 67 R 96 100
VERAPAMIL ER 66 39 98 111
PROMETHAZINE HCL 64 41 R 99 138
POLYETHYLENE GLYCOL 3350 63 57 100 36
JANUVIA 62 56 101 88
ABILIFY 61 28 102 146
METHYLPREDNISOLONE 61 48 102 159
AMIODARONE HCL 61 61 102 189
NOVOLIN 70-30 59 49 105 300
ALBUTEROL SULFATE 59 47 105 137
BACLOFEN 58 36 107 123
NOVOLIN R 57 55 108 286
INSULIN SYRINGE 55 26 109 153
DIOVAN 54 41 110 63
METOCLOPRAMIDE HCL 54 40 110 93
OXYCODONE HCL-ACETAMINOPHEN 51 43 S2 112 104
LEVETIRACETAM 51 36 112 162
MONTELUKAST SODIUM 51 29 112 194
LOVASTATIN 51 51 112 38
SEROQUEL 50 38 116 150
CEPHALEXIN 50 41 116 75
SYMBICORT 50 48 116 163
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.